109 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
7 May 24
Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
7:10am
associated with the acquisition of LG Chem’s proprietary compound LB54640. Additional increased costs were associated with salaries, benefits and stock-based … . The year-over-year increase was primarily due to increased compensation and benefits related costs associated with additional headcount to support our
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
to all of the benefits of this Certificate of Designations equally and ratably with all other Convertible Preferred Stock then outstanding.
(k
8-K
EX-99.1
8f5q8 odv6l
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
8-K
zb42 2us88l6a54e
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
8-K
EX-10.1
dajbj5ggllmt8k0o9
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
424B5
q8ichhhngqe7oni
29 Feb 24
Prospectus supplement for primary offering
4:44pm
8-K
EX-99.1
pvjevhu2
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
u37wxkoquea 7l3sf
4 Jan 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-3.1
wf1da3lnk qfmywp
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
n9ipzs8gi4njcvww1
6 Dec 23
Other Events
4:30pm
8-K
EX-99.1
qbb4fwn
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
obbqoecsln07jf89hay9
21 Aug 23
Other Events
4:30pm
8-K
EX-10.2
0dzwj4z3ytb4b
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
qthsctp n6k
3 Aug 23
Departure of Directors or Certain Officers
5:22pm